Can the meteoric rise of psychedelics and entactogens clear the legal hurdles of abuse potential assessment and rescheduling?
MDMA-assisted therapy has been on the forefront of psychedelic research for years, but more recently patient safety concerns and research ethics have come into question.
The most important psychedelic research tool you’ve never heard of and why the DEA wants to schedule it.
Experts say COMPASS’ analysis overlooked one of the crystal forms present in their sample.
The truth is that scientists don’t know enough about them. And research into any athletic-enhancing capabilities they may have is lacking.
“Obviously, bureaucracy is not a human being. People have compassion. Bureaucracies don’t always have compassion.' -- Spencer Hawkswell
Scientific research does not support his statements that psychedelics are “very potent” and “very dangerous.”
Decriminalize Nature DC is driving the effort to get the initiative on the November ballot.
UK Health Technology Assessment body raises questions over the clinical and cost-effectiveness of Spravato (esketamine).
If passed and signed by Governor Phil Scott, the law will go into effect July 1, 2020.